Glucagon-like Peptide 1-Based Drugs and Pancreatic Safety Reply
Department of Medicine and the Center for Public Health and Human Rights, Johns Hopkins University Schools of Medicine and Public Health, Baltimore, Maryland.JAMA Internal Medicine (Impact Factor: 13.12). 10/2013; 173(19):1843-4. DOI: 10.1001/jamainternmed.2013.8128
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.